Pawan Gulati

Pawan Gulati

Auto-generated profile, based on publicly available information

Pawan Gulati

Translational and Clinical Research Institute (Dermatology), Medical School, Newcastle University , Newcastle upon Tyne

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2010 in Cell Metabolism
Verified
Journal Article
Closed access
AKAdem Kalender
Adem Kalender
ASAnand Selvaraj
Anand Selvaraj
SKSo Young Kim
So Young Kim
PGPawan Gulati
Pawan Gulati
SBSophie Brûlé
Sophie Brûlé
GTGeorge Thomas
George Thomas

14 November 2016 in Nature Genetics
Verified
Journal Article
Open access
PDF file
LLLuca A Lotta
Luca A Lotta
PGPawan Gulati
Pawan Gulati
FDFelix R Day
Felix R Day
FPFelicity Payne
Felicity Payne
HOHalit Ongen
Halit Ongen
RSRobert A Scott
Robert A Scott
Luca Lotta, Robert Scott, Stephen O’Rahilly, Claudia Langenberg, David Savage, Nicholas Wareham, Inês Barroso and colleagues identify 53 genomic regions associated with insulin resistance phenotypes. Their findings suggest that limited storage capacity of peripheral adipose tissue is an important etiological component in insulin-resistant cardiometabolic disease and highlight genes and mechanisms underpinning this link. Insulin resistance is a key mediator of obesity-related cardiometabolic disease, yet the mechanisms underlying this link remain obscure. Using an integrative genomic approach, we identify 53 genomic regions associated with insulin resistance phenotypes (higher fasting insulin levels adjusted for BMI, lower HDL cholesterol levels and higher triglyceride levels) and provide evidence that their link with higher cardiometabolic risk is underpinned by an association with lower adipose mass in peripheral compartments. Using these 53 loci, we show a polygenic contribution to familial partial lipodystrophy type 1, a severe form of insulin resistance, and highlight shared molecular mechanisms in common/mild and rare/severe insulin resistance. Population-level genetic analyses combined with experiments in cellular models implicate CCDC92, DNAH10 and L3MBTL3 as previously unrecognized molecules influencing adipocyte differentiation. Our findings support the notion that limited storage capacity of peripheral adipose tissue is an important etiological component in insulin-resistant cardiometabolic disease and highlight genes and mechanisms underpinning this link.

1 May 2008 in Cell Metabolism
Verified
Journal Article
Closed access
PGPawan Gulati
Pawan Gulati
LGLawrence D. Gaspers
Lawrence D. Gaspers
SDStephen G. Dann
Stephen G. Dann
MJManel Joaquin
Manel Joaquin
TNTakahiro Nobukuni
Takahiro Nobukuni
GTGeorge Thomas
George Thomas

28 January 2013 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
PGPawan Gulati
Pawan Gulati
MCMan Ka Cheung
Man Ka Cheung
RARobin Antrobus
Robin Antrobus
CCChris D. Church
Chris D. Church
HHHeather P. Harding
Heather P. Harding
GYGiles S. H. Yeo
Giles S. H. Yeo
SNPs in the first intron of FTO ( fat mass and obesity associated ) are strongly associated with human obesity. While it is not yet formally established that this effect is mediated through the actions of the FTO protein itself, loss of function mutations in FTO or its murine homologue Fto result in severe growth retardation, and mice globally overexpressing FTO are obese. The mechanisms through which FTO influences growth and body composition are unknown. We describe a role for FTO in the coupling of amino acid levels to mammalian target of rapamycin complex 1 signaling. These findings suggest that FTO may influence body composition through playing a role in cellular nutrient sensing.

1 October 2014 in Bioscience Reports
Verified
Journal Article
Open access
PDF file
PGPawan Gulati
Pawan Gulati
EAEdward Avezov
Edward Avezov
MMMarcella Ma
Marcella Ma
RARobin Antrobus
Robin Antrobus
PLPaul Lehner
Paul Lehner
GYGiles S. H. Yeo
Giles S. H. Yeo
SNPs (single nucleotide polymorphisms) on a chromosome 16 locus encompassing FTO, as well as IRX3, 5, 6, FTM and FTL are robustly associated with human obesity. FTO catalyses the Fe(II)- and 2OG-dependent demethylation of RNA and is an AA (amino acid) sensor that couples AA levels to mTORC1 (mammalian target of rapamycin complex 1) signalling, thereby playing a key role in regulating growth and translation. However, the cellular compartment in which FTO primarily resides to perform its biochemical role is unclear. Here, we undertake live cell imaging of GFP (green fluorescent protein)-FTO, and demonstrate that FTO resides in both the nucleus and cytoplasm. We show using ‘FLIP’ (fluorescence loss in photobleaching) that a mobile FTO fraction shuttles between both compartments. We performed a proteomic study and identified XPO2 (Exportin 2), one of a family of proteins that mediates the shuttling of proteins between the nucleus and the cytoplasm, as a binding partner of FTO. Finally, using deletion studies, we show that the N-terminus of FTO is required for its ability to shuttle between the nucleus and cytoplasm. In conclusion, FTO is present in both the nucleus and cytoplasm, with a mobile fraction that shuttles between both cellular compartments, possibly by interaction with XPO2.

22 May 2012 in International Journal of Obesity
Verified
Journal Article
Open access
PDF file
MCM K Cheung
M K Cheung
PGP Gulati
P Gulati
SOS O'RAhilly
S O'RAhilly
GYG S H Yeo
G S H Yeo
Genome-wide association studies have revealed that single nucleotide polymorphisms in fat mass and obesity-associated transcript (FTO) are robustly associated with body mass index and obesity. Expression of Fto in the hypothalamic arcuate nucleus is bidirectionally regulated as a function of nutritional status; decreasing following a 48-h fast and increasing after 10-week exposure to a high-fat diet. Here, we utilize an in vitro approach to determine which nutrients could regulate FTO levels at a cellular level. Using mouse and human cell lines, we find that FTO levels are not influenced by serum starvation. We demonstrate, however, that both glucose and total amino-acid deprivation regulates FTO expression. In particular, we have found that FTO mRNA and protein levels are dramatically downregulated by total amino-acid deprivation in mouse hypothalamic N46 cells, mouse embryonic fibroblasts and in human HEK293 cells. The drop rate of Fto mRNA is faster than its rate of natural degradation, pointing to regulation at the transcriptional level, which is reversible upon amino-acid replacement. Strikingly, this downregulation was seen only with essential amino-acid deficiency and not nonessential amino acids. These data suggest that FTO might have a role in the sensing of essential amino-acid availability.